• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清脂联素、瘦素和透明质酸水平在肝硬化和非肝硬化肝细胞癌患者中的意义。

The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients.

机构信息

Biochemistry Department, Cairo University, Cairo, Egypt.

出版信息

Hum Exp Toxicol. 2012 Apr;31(4):311-21. doi: 10.1177/0960327111431091. Epub 2012 Jan 16.

DOI:10.1177/0960327111431091
PMID:22249387
Abstract

It is well established that hepatocellular carcinoma (HCC) develops in a multistep process, from chronic hepatitis, cirrhosis to HCC. Adipose tissue is not simply an energy storage organ but also a secretory organ, producing a variety of bioactive molecules known as adipokines, including adiponectin and leptin. Hyaluronic acid (HA) is an extracellular matrix protein, often associated with a variety of human cancers. Our retrospective study determines serum levels of adiponectin, leptin, and HA in HCC of cirrhotic and noncirrhotic patients and compares these levels to patients with cirrhosis and normal subjects. Noncirrhotic HCC (n = 19), cirrhotic HCC (n = 50), cirrhosis (n = 36) patients and twenty one age-, sex-, and body mass index (BMI)-matched normal healthy controls were subjected in the present study. Serum adiponectin, leptin, and HA levels were determined using enzyme-linked immunosorbent assay technique. Levels of serum adiponectin were significantly higher in the cirrhosis and cirrhotic HCC groups than in the normal subjects, whereas serum HA levels were found to significantly increase in all three patients groups. The elevation of serum leptin in our HCC patients, regardless of being cirrhotic or noncirrhotic, but not in the patients with cirrhosis, may shed some light on the significance of serum leptin level in HCC. Further studies are recommended to evaluate the prognostic value of serum leptin level in HCC.

摘要

众所周知,肝细胞癌(HCC)是在慢性肝炎、肝硬化到 HCC 的多步骤过程中发展的。脂肪组织不仅是一种储能器官,还是一种分泌器官,可产生多种生物活性分子,称为脂肪因子,包括脂联素和瘦素。透明质酸(HA)是细胞外基质蛋白,常与多种人类癌症相关。我们的回顾性研究确定了肝硬化和非肝硬化 HCC 患者以及肝硬化和正常对照患者血清中脂联素、瘦素和 HA 的水平,并将这些水平进行了比较。本研究纳入了 19 例非肝硬化 HCC、50 例肝硬化 HCC、36 例肝硬化患者和 21 例年龄、性别和体重指数(BMI)匹配的正常健康对照者。采用酶联免疫吸附试验技术测定血清脂联素、瘦素和 HA 水平。肝硬化和肝硬化 HCC 组的血清脂联素水平明显高于正常对照组,而血清 HA 水平在所有三组患者中均显著升高。我们的 HCC 患者(无论是否肝硬化)血清瘦素升高,但肝硬化患者的血清瘦素没有升高,这可能提示血清瘦素水平在 HCC 中的意义。建议进一步研究以评估血清瘦素水平在 HCC 中的预后价值。

相似文献

1
The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients.血清脂联素、瘦素和透明质酸水平在肝硬化和非肝硬化肝细胞癌患者中的意义。
Hum Exp Toxicol. 2012 Apr;31(4):311-21. doi: 10.1177/0960327111431091. Epub 2012 Jan 16.
2
Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis.胰岛素抵抗、血清瘦素、脂联素水平与丙型肝炎肝硬化的结局。
J Hepatol. 2010 Nov;53(5):827-33. doi: 10.1016/j.jhep.2010.04.035. Epub 2010 Jul 14.
3
The promoting effect of adiponectin in hepatocellular carcinoma.脂联素在肝细胞癌中的促进作用。
J Surg Oncol. 2012 Aug 1;106(2):181-7. doi: 10.1002/jso.23059. Epub 2012 Jan 27.
4
Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.肝硬化和肝细胞癌患者血清血管生成素-2水平升高。
Am J Gastroenterol. 2007 Nov;102(11):2471-81. doi: 10.1111/j.1572-0241.2007.01377.x. Epub 2007 Jun 20.
5
Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.评估血清簇集素作为乙型肝炎病毒相关性肝硬化患者肝细胞癌监测工具的价值。
J Gastroenterol Hepatol. 2010 Jun;25(6):1123-8. doi: 10.1111/j.1440-1746.2009.06205.x.
6
Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.血清IV型胶原蛋白在肝癌以及肝硬化中均有升高。
Anticancer Res. 1995 Nov-Dec;15(6B):2777-80.
7
Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.血清高尔基糖蛋白-3在鉴别肝细胞癌与非恶性慢性肝病和其他肝癌中的诊断作用。
J Gastroenterol Hepatol. 2010 Jan;25(1):129-37. doi: 10.1111/j.1440-1746.2009.05988.x. Epub 2009 Sep 27.
8
Serum surrogate markers of liver fibrosis in primary biliary cirrhosis.原发性胆汁性肝硬化的血清肝纤维化标志物。
Eur J Intern Med. 2011 Feb;22(1):77-83. doi: 10.1016/j.ejim.2010.10.002. Epub 2010 Nov 13.
9
Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.Child-Pugh A级肝硬化患者的锰超氧化物歧化酶活性与肝细胞癌发病率:一项7年随访研究
Liver Int. 2007 Aug;27(6):791-7. doi: 10.1111/j.1478-3231.2007.01485.x.
10
Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.非肝硬化肝脏中的肝细胞癌:与肝硬化相关肝细胞癌的比较。
Q J Med. 1984 Summer;53(211):391-400.

引用本文的文献

1
Correlations between circulating adipokines and hepatocellular carcinoma: a Systematic Review and meta-analysis.循环脂肪因子与肝细胞癌之间的相关性:一项系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2025 Jun 18;16:1548924. doi: 10.3389/fendo.2025.1548924. eCollection 2025.
2
Adiponectin as a biomarker in liver cirrhosis-A systematic review and meta-analysis.脂联素作为肝硬化的生物标志物——一项系统评价与荟萃分析
Eur J Clin Invest. 2025 Jan;55(1):e14328. doi: 10.1111/eci.14328. Epub 2024 Nov 2.
3
Clinical significances of several fibrotic markers for prognosis in hepatocellular carcinoma patients who underwent hepatectomy.
几种纤维化标志物对接受肝切除术的肝细胞癌患者预后的临床意义。
Transl Cancer Res. 2024 May 31;13(5):2332-2345. doi: 10.21037/tcr-24-94. Epub 2024 May 29.
4
New advances of adiponectin in regulating obesity and related metabolic syndromes.脂联素在调节肥胖及相关代谢综合征方面的新进展。
J Pharm Anal. 2024 May;14(5):100913. doi: 10.1016/j.jpha.2023.12.003. Epub 2023 Dec 13.
5
Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.非酒精性脂肪性肝病相关肝细胞癌中的肿瘤坏死因子-α与脂联素
Cancers (Basel). 2023 Nov 6;15(21):5306. doi: 10.3390/cancers15215306.
6
Role of Leptin in Non-Alcoholic Fatty Liver Disease.瘦素在非酒精性脂肪性肝病中的作用。
Biomedicines. 2021 Jun 30;9(7):762. doi: 10.3390/biomedicines9070762.
7
Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC.重塑线粒体可塑性:从非酒精性脂肪性肝病/非酒精性脂肪性肝炎到肝细胞癌的关键开关。
Int J Mol Sci. 2021 Apr 17;22(8):4173. doi: 10.3390/ijms22084173.
8
The association of leptin and adiponectin with hepatocellular carcinoma risk and prognosis: a combination of traditional, survival, and dose-response meta-analysis.瘦素和脂联素与肝细胞癌风险和预后的关联:传统荟萃分析、生存分析和剂量反应荟萃分析的结合。
BMC Cancer. 2020 Nov 30;20(1):1167. doi: 10.1186/s12885-020-07651-1.
9
Leptin as a Key Player in Insulin Resistance of Liver Cirrhosis? A Cross-Sectional Study in Liver Transplant Candidates.瘦素是肝硬化胰岛素抵抗的关键因素?一项针对肝移植候选者的横断面研究。
J Clin Med. 2020 Feb 19;9(2):560. doi: 10.3390/jcm9020560.
10
Significance of Serum Adiponectin and Insulin Resistance Levels in Diagnosis of Egyptian Patients with Chronic Liver Disease and HCC.血清脂联素和胰岛素抵抗水平在埃及慢性肝病和肝癌患者诊断中的意义
Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1833-1839. doi: 10.31557/APJCP.2019.20.6.1833.